about
Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development.FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosisCollecting duct carcinoma of the kidney: an immunohistochemical study of 11 casesFez1/Lzts1 a new mitotic regulator implicated in cancer developmentMicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell CarcinomaThe leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney developmentDeletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor developmentAllelic imbalance of 8p indicates poor survival in gastric cancerLZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer.Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasisLZTS2 is a novel beta-catenin-interacting protein and regulates the nuclear export of beta-catenin.FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells.Loss of Leucine Zipper Putative Tumor Suppressor 1 (LZTS1) Expression Contributes to Lymph Node Metastasis of Breast Invasive Micropapillary CarcinomaPossibility of the use of public microarray database for identifying significant genes associated with oral squamous cell carcinomaTargeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.Frequent loss of heterozygosity at 8p22 chromosomal region in diffuse type of gastric cancer.Epigenetic silencing of SMOC1 in traditional serrated adenoma and colorectal cancer.
P2860
Q24299543-29BA4B69-62AD-4AD7-8D6B-626944F3496BQ24555213-57ADF1CF-FA8E-4442-B1AC-B4E78A68232FQ24793771-92AAD81D-E8F5-4972-8D85-84B857E2E9A3Q28397171-CCE1A324-383B-4220-B08C-0F06C98F2C47Q28546971-07FF113B-7A71-465B-8D7A-6D23C380B692Q28588665-8E381021-4AF8-45E2-862F-13BE7361D768Q28591535-B83E0A81-1389-4921-80F8-82DD8286CBB0Q30444683-55C33C2E-47D4-4EF3-88C4-564FEBB98C73Q33572318-2B8F390F-B47D-49A7-B017-22B612E65505Q34081068-29C754F7-4CF1-4B33-A925-209AF1D6A1BFQ35131658-95CFF2C9-04D6-4233-B0F4-4CF530850BBBQ35788955-ED93D268-A9B5-4FA2-A840-2F3AD60FD9A4Q35998703-7228B07D-9246-4CD7-993A-098EED674AB6Q36330529-BABF5E30-AA56-4885-BE4F-BD3E15D9135EQ37718444-F1593062-F8FF-40C2-8FDA-271A7C86A04AQ42911521-2766C101-7AF1-481E-AF8D-37D52238D555Q50043048-82FC8AFE-1022-4997-AE11-69A3E5FB336B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Fez1/lzts1 alterations in gastric carcinoma.
@ast
Fez1/lzts1 alterations in gastric carcinoma.
@en
type
label
Fez1/lzts1 alterations in gastric carcinoma.
@ast
Fez1/lzts1 alterations in gastric carcinoma.
@en
prefLabel
Fez1/lzts1 alterations in gastric carcinoma.
@ast
Fez1/lzts1 alterations in gastric carcinoma.
@en
P2093
P1476
Fez1/lzts1 alterations in gastric carcinoma
@en
P2093
A Vecchione
F Trapasso
J F Tamburrino
Y Murakumo
P304
P407
P577
2001-06-01T00:00:00Z